author-photo

Seiji Niho

Eli Lilly and Company

266

Papers

3769

Citations

Citation Trend

Filter By

Papers (186) Sort By

Journal Conference Others

P45.04 Phase II Study of Brigatinib in ROS1 Positive Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated with Crizotinib: Barossa Cohort 2

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
O11-3 Phase 2 trial of atezolizumab with bevacizumab for patients with PD-L1 high non-Sq NSCLC (WJOG10718L/At Be Study)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study

2021 Translational lung cancer research
Show All
- Source
- Cite
- Save
Citations (0)
Phase II study of brigatinib in ROS1 positive non-small cell lung cancer (NSCLC) patients previously treated with crizotinib: Barossa cohort 2.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.

2021 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (1)
P76.67 Safety and Efficacy of First-Line Dacomitinib in Advanced Non-Small Cell Lung Cancer by EGFR Mutation SUBtype in ARCHER 1050

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1188P Concurrent chemoradiotherapy with cisplatin + S-1 for locally advanced non-small cell lung cancer: IPD meta-analysis

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer.

2020 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (5)